In 8 volunteers blood and urine bismuth levels were detected after a 5 day course of tripotassium dicitrato-bismuthate and rose further with increasing dose. In 24 patients, blood and urine bismuth were measured on the last day of treatment. There was no significant difference (p>0.2) in either blood or urine bismuth levels amongst patients treated for 4, 5, or 6 weeks with colloidal bismuth. None of the blood level measurements exceeded 50 μg/l. Bismuth was slowly eliminated in the urine after stopping treatment.link_to_subscribed_fulltex
Thirty-five patients with duodenal ulcers were treated with tripotassium dicitrato-bismuthate (TDB) ...
Here, bismuth-based nanomaterials (Bi-based NMs) are introduced as promising theranostic agents to e...
Summary: Fifty three patients with endoscopically proven duodenal ulceration have cooperated in a cl...
Bismuth levels in blood and brain of rats have been measured following acute or subchronic administr...
Background. Bismuth-containing quadruple therapy achieves higher eradication rate of Helicobacter py...
A colloidal bismuth preparation, tripotassium dicitrato-bismuthate, was given (172 mg/kg body weight...
In 1933 Levaditi (1) reported the status of the prevention and therapy of syphilis with bismuth. In ...
Undoubtedly the most important of the bismuth anti-luetics, from a clinical standpoint today, are th...
INTRODUCTION: A fixed-dose association of bismuth subcitrate, metronidazole and tetracycline (BMT) (...
The bismuth contents of various digested urine samples and prescription medicines were determined by...
SUMMARY Forty patients with duodenal ulcer were randomly allocated to treatment with either tripotas...
Bismuth complexes have been widely used in clinical treatment as antiulcer drugs. However, different...
Consumption and production of bismuth compounds are increasing, however, a little information on the...
AIM: To evaluate the bioequivalence of ranitidine and bismuth derived from two compound preparations...
We developed a simple method for the analysis of bis-muth (Bi) in biological tissue, using wet diges...
Thirty-five patients with duodenal ulcers were treated with tripotassium dicitrato-bismuthate (TDB) ...
Here, bismuth-based nanomaterials (Bi-based NMs) are introduced as promising theranostic agents to e...
Summary: Fifty three patients with endoscopically proven duodenal ulceration have cooperated in a cl...
Bismuth levels in blood and brain of rats have been measured following acute or subchronic administr...
Background. Bismuth-containing quadruple therapy achieves higher eradication rate of Helicobacter py...
A colloidal bismuth preparation, tripotassium dicitrato-bismuthate, was given (172 mg/kg body weight...
In 1933 Levaditi (1) reported the status of the prevention and therapy of syphilis with bismuth. In ...
Undoubtedly the most important of the bismuth anti-luetics, from a clinical standpoint today, are th...
INTRODUCTION: A fixed-dose association of bismuth subcitrate, metronidazole and tetracycline (BMT) (...
The bismuth contents of various digested urine samples and prescription medicines were determined by...
SUMMARY Forty patients with duodenal ulcer were randomly allocated to treatment with either tripotas...
Bismuth complexes have been widely used in clinical treatment as antiulcer drugs. However, different...
Consumption and production of bismuth compounds are increasing, however, a little information on the...
AIM: To evaluate the bioequivalence of ranitidine and bismuth derived from two compound preparations...
We developed a simple method for the analysis of bis-muth (Bi) in biological tissue, using wet diges...
Thirty-five patients with duodenal ulcers were treated with tripotassium dicitrato-bismuthate (TDB) ...
Here, bismuth-based nanomaterials (Bi-based NMs) are introduced as promising theranostic agents to e...
Summary: Fifty three patients with endoscopically proven duodenal ulceration have cooperated in a cl...